CVS vs RNXT · P/E 16, rev $402.07B vs rev $266.0K
CVS Health Corp (CVS) versus RenovoRx Inc (RNXT) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
RenovoRx Inc (RNXT) is a biotechnology company listed on US.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported RNXT revenue for 2025-09-30 was $266.0K. Net income was -$2.9M. Revenue was down 37.0% from 2025-06-30 to 2025-09-30. RNXT currently screens at market cap $47.0M.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. RNXT currently screens at market cap $47.0M.
Not investment advice. Open the CVS and RNXT stock pages for the full models.
Not investment advice.